Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166270 · ClinicalTrials.gov registry record · NA
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
A NA study, sponsored by InSightec.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00166270 is a NA study that has completed, run by InSightec. The registered enrollment target is 70 participants.
The verdict
NCT00166270, a NA study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a prospective, nonrandomized, multi-center study to evaluate the safety and effectiveness of ExAblate in the treatment of uterine fibroids. All patients will be treated and then followed for 36 months to evaluate the change in their fibroid symptoms.
Interventions
- DEVICE ExAblate 2000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166270
The ClinicalTrials.gov registry entry for NCT00166270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExAblate 2000 is the first listed.
NCT00166270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166270 about?
NCT00166270 is a clinical study titled "MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids". This is a prospective, nonrandomized, multi-center study to evaluate the safety and effectiveness of ExAblate in the treatment of uterine fibroids. All patients will be treated and then followed for 36 months to evaluate the change in their fibroid symptoms.
What is the current status of trial NCT00166270?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2005-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00166270?
The interventions under investigation include: ExAblate 2000 (DEVICE).
Who is sponsoring clinical trial NCT00166270?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.